PMC:7200337 / 117401-118019 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T666 230-236 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T156 558-561 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T22358 68-72 Chemical denotes Neon http://purl.obolibrary.org/obo/CHEBI_33310
T75 406-413 Chemical denotes Celsius http://purl.obolibrary.org/obo/CHEBI_145500

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T63 230-236 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T698 0-24 Sentence denotes Declaration of Interests
T699 25-251 Sentence denotes N.B. serves as an advisor/board member for Neon, Checkpoint Sciences, Primevax, Novartis, Array BioPharma, Roche, Avidea, Boeringer Ingelheim, Rome Therapeutics, Roswell Park, and the Parker Institute for Cancer Immunotherapy.
T700 252-362 Sentence denotes N.B. receives research support from the Parker Insitute, Novocure, Celldex, Genentech, Oncovir, and Regeneron.
T701 363-482 Sentence denotes M.M. serves as an advisor/board member for Celsius, Pionyr, Compugen, Myeloids and Innate pharma and ad hoc for Takeda.
T702 483-552 Sentence denotes M.M. receives research support from Regeneron, Takeda, and Genentech.
T703 553-618 Sentence denotes A.M. has equity in Gilead Sciences and Regeneron Pharmaceuticals.